Trials / Completed
CompletedNCT01146470
The Influence of Red Grape Cells on Blood Pressure Vascular Function in People With Hypertension
A Single-Center, Double-blind, Random, Parallel Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Other Government
- Sex
- All
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study hypothesis is that 3 Months Daily Supplementation of RGC will effect blood pressure and vascular function. This will be a single-center, double-blind, random, parallel controlled Study. Study population will include 60 subjects, who will be divided randomly into three groups. The first group will get RGC 200mg, the second group will get RGC 400mg, and the third group will get 200mg placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | RGC | dosage of Red Grape Cells once a day, during 3 months |
| DIETARY_SUPPLEMENT | Placebo | dosage of Placebo once a day, during 3 months |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-06-17
- Last updated
- 2013-02-20
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01146470. Inclusion in this directory is not an endorsement.